Tech Company Financing Transactions
Avelas Biosciences Funding Round
Avelas Biosciences closed a $7.7 million Series A funding round on 12/7/2012. Investors included Avalon Ventures.
Transaction Overview
Company Name
Announced On
12/7/2012
Transaction Type
Venture Equity
Amount
$7,650,000
Round
Series A
Investors
Avalon Ventures (Jay Lichter)
Proceeds Purpose
Avelas will use the funding to advance the Avelas Cancer Illuminator (ACI) towards clinical studies for the visualization of cancerous lymph nodes in breast cancer patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11099 North Torrey Pines Rd. 180
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Medical Officer
Steven Chen
Chief Scientific Officer
Jesus Gonzalez
VP - Bus. Development
William Stratton
Browse more venture capital transactions:
Prev: 12/7/2012: Knowland Group venture capital transaction
Next: 12/7/2012: Udemy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs